In prostate and non-small cell lung cancer cells, epidermal growth factor (EGF) can upregulate the expression of Nav1.7 and promote the migration of cancer cells (52, 53) or promote cell invasion through the ERK1 /2 pathway, respectively (54). This evidence concerns the gene SCN9A and non-small cell lung carcinoma.